Sep 02,2021

Sugar.fit to raise $10M in Seed Funding

Healthcare startup Sugar.fit on Friday said it is set to raise $10 million in seed funding from health and fitness firm Cure.fit along with early-stage venture capital fund Endiya Partners and Tanglin Venture. The investment is expected to close by September 2021.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Sep 29,2021

The healthtech Nutrix raises capital and prepares the debut of its technology to combat diabetes

The startup, which raised US$250,000 with a Polish fund, is about to carry out new clinical tests of its device that measures glucose through saliva. In parallel and by the end of this year, it will launch a mobile app for diabetics.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Oct 08,2021

London-based startup Habitual lands $2.3M seed funding

UK digital health startup Habitual has scored $2.3 million (£1.7M) in seed round funding. The London-based firm offers a weight loss programme for people with type 2 diabetes or prediabetes, which combines evidence-based food replacement with digital support. Berlin-based Atlantic Food Labs, led the round with existing investors Seedcamp and MMC also participating.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Oct 13,2021

Lark Health Raises $100 Million Series D Funding Round Led by Deerfield Management

Lark Health today announced that it has closed a $100 million Series D funding round led by Deerfield Management Company. The funding round also includes crossover fund PFM Health Sciences, as well as returning investors Franklin Templeton, King River Capital, Castlepeak, IPD, Olive Tree Capital, and Marvell Technology cofounder Weili Dai. Lark plans to use the funds to expand its virtual care integrations to more payers.

FUNDING SERIES D
View Analyst & Ambassador Comments
Go to original news
Oct 20,2021

Microtech Medical raises $255M in Hong Kong debut amid glut of med-tech offerings

Microtech Medical (Hangzhou) Co. Ltd. raised around HK$1.98 billion (US$254.53 million) via its listing on the Hong Kong stock exchange, becoming the latest in a flood of med-tech companies listing in the city.

FUNDING IPO
View Analyst & Ambassador Comments
Go to original news
Oct 29,2021

Better Therapeutics Closes Business Combination and Debuts on Nasdaq

Better Therapeutics, Inc., a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced the completion of its business combination with Mountain Crest Acquisition Corp II, a publicly traded special purpose acquisition corporation or SPAC. The transaction generated approximately $70 million in gross proceeds from the business combination, a private investment in a public equity from leading healthcare investors led by Farallon Capital Management, RS Investments, Sectoral Asset Management, and Monashee Investment Management, and the first tranche of a credit facility from Hercules Capital that was contingent on the closing of the business combination. The company has access to an additional $40 million from the Hercules Capital credit facility subject to certain milestones.

FUNDING POST-IPO EQUITY
View Analyst & Ambassador Comments
Go to original news
Nov 02,2021

Biolinq Raises $100 Million, Unveils Micro-Sensing Technology in the Skin

Biolinq Incorporated, a medical device company developing a continuous glucose sensor with a novel integrated display on its wearable device, has announced the closing of a $100 million Series B financing round led by RiverVest Venture Partners. This record private capital raise in the continuous glucose monitoring space includes participation from T&W Medical, AXA IM Alts, Global Health Investment Corporation, Ascensia Diabetes Care, Longevity Vision Fund, Falcon Edge Capital, Aphelion Capital, M Ventures, Hikma Ventures, Senvest, The Broe Group, Taisho Pharmaceutical, Cirrus Logic, EOFlow, Able Partners and the JDRF T1D Fund.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Nov 12,2021

Tula Health Secures $8M from Investors

Tula Health received $8.3 million funding from the investors according to the SEC form registered.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Dec 23,2021

Danish medtech startup Hedia raises €3 million and plans European expansion

Medtech startup from Copenhagen, Hedia, has just raised an additional €3 million for its technology to manage diabetes. The company is backed by Novo-heirs, and we reckoned it was one to watch back in 2019.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Dec 31,2021

Onalabs opens an investment channel of 1 million euros in Capital Cell

Onalabs Inno-Hub, the biotechnology startup specialized in medical and sports monitoring devices, opens up to the entry of capital with an investment line of one million euros in the Capital Cell platform. With this, they will give a definitive boost to the development and commercialization of the HAD10 and L10 devices designed for the monitoring of chronic patients and athletes, respectively.

FUNDING EQUITY
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES